Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Howlader N, Noone A, Krapcho M, Garshell J, Neyman N, Altekruse S, et al. SEER cancer statistics review, 1975–2010.[Based on the November 2012 SEER data submission, posted to the SEER web site, April 2013.]. Bethesda, MD: National Cancer Institute. 2013;9.
2. Muss HB, Berry DA, Cirrincione C, Budman DR, Henderson IC, Citron ML et al (2007) Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience. J Clin Oncol 25(24):3699–3704
3. Goldberg RM, Tabah-Fisch I, Bleiberg H, de Gramont A, Tournigand C, Andre T et al (2006) Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol 24(25):4085–4091. https://doi.org/10.1200/JCO.2006.06.9039
4. Figer A, Perez-Staub N, Carola E, Tournigand C, Lledo G, Flesch M et al (2007) FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study. Cancer 110(12):2666–2671. https://doi.org/10.1002/cncr.23091
5. Handforth C, Clegg A, Young C, Simpkins S, Seymour MT, Selby PJ et al (2015) The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol 26(6):1091–1101. https://doi.org/10.1093/annonc/mdu540
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献